WENDY MARUSSICH: Open Payments
NPI 1316635956 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 14 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $26 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $275 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| Lundbeck LLC | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
Products named: VRAYLAR, Auvelity, REXULTI, CAPLYTA.
Industry payments across CA — which companies pay providers there.
